Provided by Tiger Fintech (Singapore) Pte. Ltd.

Benitec Biopharma

15.05
+0.64004.44%
Post-market: 15.050.00000.00%16:05 EDT
Volume:64.76K
Turnover:978.31K
Market Cap:383.69M
PE:-7.77
High:15.69
Open:14.42
Low:14.42
Close:14.41
Loading ...
Aug 07, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Aug 03, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Aug 03, 2023

Correspondence

Form CORRESP - Correspondence
Aug 03, 2023

Correspondence

Form CORRESP - Correspondence
Jul 31, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Jul 26, 2023

Major Issues Report

Form 8-K - Current report
Jul 07, 2023

Public Prospectus

Form S-1 - General form for registration of securities under the Securities Act of 1933
Jun 26, 2023

Major Issues Report

Form 8-K - Current report
Jun 15, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Major Issues Report

Form 8-K - Current report
May 15, 2023

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 18, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Mar 08, 2023

Major Issues Report

8-K - Current report
Feb 14, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 13, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 13, 2023

Major Issues Report

8-K - Current report
Feb 08, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 23, 2023

Major Issues Report

8-K - Current report
Dec 15, 2022

Correspondence

CORRESP [Cover] - Correspondence